File this under Truth-is-Stranger-Than-Fiction. First Pfizer announced that it wants to market a combination of ivermectin and zinc (which we predicted it would do months ago, dubbing it “Pfizermectin”). Now Merck literally wants to red-pill the planet.

Pharmaceutical giant Merck and its partner, Ridgeback Biotherapeutics, announced that its recent study showed that treatment with the new drug, molnupiravir, within five days of COVID-19 symptoms reduced the rate of hospitalization and death by half as compared with those who received a placebo.

The study tracked 775 adults with mild-to-moderate COVID-19 infections and who were considered at high risk for developing severe disease because of underlying comorbidities, such as obesity, diabetes, or heart disease. The results of the study have not yet been peer reviewed.

7.3% of patients taking molnupiravir were either hospitalized or died at the end of 30 days, compared with 14.1% of those who were given the placebo, however, there were no deaths among those who received the drug, but eight in the placebo group died, according to Merck.

The irony in all this is that of all the colors of the rainbow and all the various shades, tones, and possible combinations, Merck has chosen to go with an all-red pill.

If only […]


Trump Won Flag
MyPillow Support Conservative Media

Promo for Mike Lindell’s New Daily Show

Our Gold Guy America First
Freedom Phone 3

All ORIGINAL content on this site is © 2021 NOQ Report. All REPUBLISHED content has received direct or implied permission for reproduction.

With that said, our content may be reproduced and distributed as long as it has a link to the original source and the author is credited prominently. We don’t mind you using our content as long as you help out by giving us credit with a prominent link. If you feel like giving us a tip for the content, we will not object!

JD Rucker – EIC

You Might Like
Learn more about RevenueStripe...